OCALIVA
Peakobeticholic acid
NDAORALTABLETPriority Review
Approved
May 2016
Lifecycle
Peak
Competitive Pressure
0/100
Clinical Trials
3
Clinical Trials (3)
Linerixibat and Obeticholic Acid Drug Interaction Study in Healthy Adult Participants
Started Nov 2021
52 enrolled
Pruritus
Study of Obeticholic Acid（OCA） Combination With Ursodeoxycholic Acid (UDCA) in Patients With Primay Biliary Cirrhosis (PBC)
Started Jul 2021
Linerixibat and Obeticholic Acid Drug Interaction Study in Healthy Subjects
Started Aug 2019
19 enrolled
Cholestasis
Loss of Exclusivity
LOE Date
Apr 26, 2036
123 months away
Patent Expiry
Apr 26, 2036
External Resources